| Cancer type | Cell line | Effects | Reference |
| Bladder | HTB-9 | Attenuation of PI3K/AKT pathway, antiproliferation, inhibition of epithelial-mesenchymal transition | [118] |
| Breast | MCF-7 | Induced phosphorylation of MAPK and p38, ROS production, antiproliferation, apoptosis, | [119] | MDA-MB-231 | Induced phosphorylation of p38, antitumour in vivo | [119] | MDA-MB-468, T-47D cells | G1 phase arrest, upregulation of Bax, downregulation of surviving, apoptosis, inhibition of Akt | [120] | BT549 | Reduction of TWIST1 expression, anti-invasion, antimetastasis | [121] | Cholangiocarcinomas | TFK-1, HuCCT1 | G2/M arrest, inactivation of PI3K/Akt and NF-ĸB pathways | [122] |
| Colon | Caco-2, HCT-116, LoVo, HT-29 | Antiproliferation | [123] | DLD-1 | Antiproliferation, apoptosis, phosphorylation of MAPK, ERK, JNK, and p38 | [123] | Glioblastoma | U-87, CCF-STTG1 | Cytotoxicity, antimigration, anti-invasion, antiadhesion, reduction of FAK phosphorylation and ERK expression | [124] | Lung | A549 | Reduction of ERK phosphorylation, antiproliferation, antimigration, anti-invasion, inhibition of p16, MMP2, MMP9 | [125] |
|
|